Live Events

This Advanced Pediatric Hemophilia Early Arthropathy Detection and Ultrasound (HEAD-US) Course is designed for physical therapists, physicians, and advanced practice providers with prior ultrasound experience seeking to enhance their skills in comprehensive pediatric joint assessment, muscle injury evaluation, and scoring of hemophilic arthropathy using the Hemophilic Arthropathy Early Detection with Ultrasound (HEAD-US) protocol. This intensive two-day course provides an in-depth review of ultrasound techniques used for imaging both healthy and affected pediatric joints (elbows, knees, and ankles), with a focus on advanced pathology detection and practical hands-on sessions under expert tutoring. Participants will refine their expertise in HEAD-US scoring, engage in live-case scanning and scoring, and undergo self-testing calibration exercises on a large dataset of scans. Additional sessions will address synovial and osteochondral mimickers, image interpretation pitfalls, and guidelines for acquiring standardized imaging documentation for external reading. Through expert-led interactive sessions, attendees will gain confidence to apply advanced ultrasound techniques into clinical practice. Join us for a specialized training experience led by experts Drs. Carlo Martinoli and Nihal Bakeer along with the highly experienced Innovative Hematology MSKUS team of physicians and physical therapists led by Dr. Kyle Davis.

Not sure which course is right for you?
Prospective attendees are advised to carefully review the Course Comparison Chart/Eligibility Criteria for the Basic and Advanced courses before applying to ensure the chosen course aligns with your educational needs.

At the conclusion of this live activity, the participants should be better able to:

• Master advanced pediatric MSK and joint ultrasound scanning
  Gain proficiency in ultrasound scanning of both healthy and arthropathic pediatric joints and in accurate image interpretation through deep understanding of pediatric skeletal maturation as well as imaging pitfalls and nuances. Practical sessions will incorporate "tips and tricks" to consolidate knowledge and enhance scanning confidence
• Enhance interpretation and scoring skills using HEAD-US
  Deepen understanding of the HEAD-US scoring system through structured calibration exercises, live case scanning, and real-time scoring to improve diagnostic accuracy and interobserver reliability.
• Recognize and interpret advanced pathological findings
  Identify and differentiate key pathological ultrasound findings in pediatric joints and muscles, including synovial hypertrophy, hemarthrosis, osteochondral changes, and muscle hematomas. Differential diagnoses will be described to avoid misinterpretation and support accurate clinical assessment.

Physical therapists, physicians, and advance practice providers who currently are, and have been, working at a Hemophilia Treatment Center (HTC) for at least six (6) months.

To attend the Advanced Pediatric Hemophilia Early Arthropathy Detection and Ultrasound (HEAD-US) course, you must meet the following criteria:

• Be employed at a Hemophilia Treatment Center (HTC) in a bleeding disorder patient-facing role for at least six (6) months.
• Provide care to pediatric patients. Lifespan providers are also eligible to apply.
• Have access to a point-of-care MSKUS device at HTC place of employment.
• Work at an HTC that intends to have dedicated staff to perform MSKUS.
• Need to have demonstrated proficiency scanning patients using point-of-care ultrasound and be able to identify normal joint anatomy in ultrasound scanning planes.
• Prior MSKUS experience is required for this course. Applicants must have previously completed the Basic Pediatric Hemophilia Early Arthropathy Detection and Ultrasound (HEAD-US) Course or other equivalent training.
• We will accept up to two (2) individuals from the same HTC to attend the Beginner course.
• Submitted applications will automatically be sent to the Regional Administrator for review/approval; their review/approval of the application is a required step to confirm registration acceptance at the program.
• Prospective attendees are advised to carefully review the Description and Learning Objectives for both the Basic and Advanced courses before applying to ensure the chosen course aligns with your educational needs. Course Comparison Chart/Eligibility Criteria
  • Apply for this program by completing the Application Form.
  • Apply Now

• There is no registration fee to attend a Partners Program.
• Once registered, you will be contacted at least 4 weeks before the program with logistical details, including air and ground transportation and hotel information. All registrants are encouraged to read the Partners Travel Policy to understand costs that are covered and costs that you may incur.
• The Partners in Bleeding Disorders Education Program is supported by an independent medical education grant(s). Travel and lodging for program participants are made possible by an at-will contribution from the Indiana Hemophilia & Thrombosis Center.

• Upon attending any Partners in Bleeding Disorders Education Program meetings or special events, you consent to interview(s), photography, audio recording, video recording and Partners release, publication, exhibition, inclusion on websites, social media, or any other purpose by Partners and its employees or affiliates.
• Please note that your contact information as stated in your profile may be made available to program attendees. Sharing of contact information with attendees at the program you attend is for the purpose of networking with colleagues.

• August 7-8, 2025

Apply Now

The Advanced Topics I for the Nursing Care Team aims to enable the learner to expand upon the basic hemophilia management knowledge base including pharmacological treatments, using current literature and best practice review, case study analysis, professional networking, and methods designed to raise care quality for persons with hemophilia treated within the federally recognized U.S. Hemophilia Treatment Center (HTC) Network.

At the conclusion of this live activity, the participants should be better able to:

• Discuss considerations, controversies, and resources in the management of hemophilia in women
• Characterize inhibitor development, risk factors, and treatment methods in different types of hemophilia
• Recall FVIII immune tolerance regimens and expected outcomes for persons with hemophilia with FVIII inhibitors
• Translate the rapidly evolving landscape of hemophilia treatment options
• Identify orthopedic challenges and interventions for individuals with hemophilia
• Develop a professional mentoring network within the federally recognized U.S. Hemophilia Treatment Center (HTC) Network

Hemophilia treatment center nurses, advanced practice providers, pharmacists, and other members of the healthcare team who have treated persons with bleeding disorders for at least two (2) years.

In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

ANCC credits will be offered.

To attend this activity, you must meet the following criteria:

• Be employed at a U.S. federally recognized HTC as a nurse, nurse practitioner, physician assistant, pharmacist, or similar role for at least two (2) years.
• Obtain approval to attend from Regional Administrator via automated process upon submission of application.
  • Apply for this program by completing the Application Form.

• There is no registration fee to attend a Partners Program.
• Once registered, you will be contacted at least 4 weeks before the program with logistical details, including air and ground transportation and hotel information. All registrants are encouraged to read the Partners Travel Policy to understand costs that are covered and costs that you may incur.
• Partners in Bleeding Disorders Education Program is supported by an independent medical education grant(s). Travel and lodging for program participants are made possible by an at-will contribution from the Indiana Hemophilia & Thrombosis Center.

• October 6-8, 2025

To enhance the ability of the experienced social worker to provide psychosocial support to persons with bleeding disorders in a family-centered care environment using peer-reviewed literature, patient case studies, group discussion, and professional networking. The content level of this activity is advanced.

Learning Objectives are currently in development and will be provide to program attendees prior to program commencement.

Topics* 

• Social Determinants of Health in Bleeding Disorders
• Women and Girls with Bleeding Disorders - Advocacy and Coping
• Aging Considerations for Patients with Bleeding Disorders
• Healthcare Transition - A Spectrum Rather than a Destination
• Treatment Adherence
• Medical Trauma in Bleeding Disorders
• Trauma-Informed Care in Bleeding Disorders
• Assessment and Screening - Practical, In-the-Moment Applications
• Empowering Social Workers to Advocate for their Role in Gene Therapy

* Topics subject to change

This activity is designed for social workers and other psychosocial professionals who currently are and have been caring for persons with bleeding disorders in the federally recognized U.S. Hemophilia Treatment Center (HTC) network for at least two (2) years and wish to expand clinical decision-making, evaluation, and assessment skills beyond the level of Basic Partners Program for Clinical Staff.?

In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

As a Jointly Accredited Organization, University of Nebraska Medical Center is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit.
ASWB ACE credits will be offered.

To attend this activity, you must meet the following criteria:

• Be employed at a U.S. federally recognized HTC as a social worker and/or other psychosocial professional for at least two (2) years.
• Obtain approval to attend from Regional Administrator via automated process upon submission of application.
  • Apply for this program by completing the Application Form.

• There is no registration fee to attend a Partners Program.
• Once registered, you will be contacted at least 4 weeks before the program with logistical details, including air and ground transportation and hotel information. All registrants are encouraged to read the Partners Travel Policy to understand costs that are covered and costs that you may incur.
• Partners in Bleeding Disorders Education Program is supported by an independent medical education grant(s). Travel and lodging for program participants are made possible by an at-will contribution from the Indiana Hemophilia & Thrombosis Center.

• October 27-29, 2025

Apply Now